Cargando…
The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age
BACKGROUND: The incidence of gout rises with increasing age. Management of elderly (≥65 years) gout patients can be challenging due to high rates of comorbidities, such as renal impairment and cardiovascular disease, and concomitant medication use. However, there is little data specifically addressi...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3368715/ https://www.ncbi.nlm.nih.gov/pubmed/22436129 http://dx.doi.org/10.1186/1471-2318-12-11 |